HK1161542A1 - 用於刺激免疫反應的產品和方法 - Google Patents

用於刺激免疫反應的產品和方法

Info

Publication number
HK1161542A1
HK1161542A1 HK12101706.9A HK12101706A HK1161542A1 HK 1161542 A1 HK1161542 A1 HK 1161542A1 HK 12101706 A HK12101706 A HK 12101706A HK 1161542 A1 HK1161542 A1 HK 1161542A1
Authority
HK
Hong Kong
Prior art keywords
stimulating
products
methods
immune response
immune
Prior art date
Application number
HK12101706.9A
Other languages
English (en)
Inventor
法存多．巴蒂斯塔
尤利婭．埃克爾-多爾納
帕特里西亞．巴拉爾
溫琴佐．塞倫多羅
Original Assignee
Blink Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blink Therapeutics Ltd filed Critical Blink Therapeutics Ltd
Publication of HK1161542A1 publication Critical patent/HK1161542A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK12101706.9A 2008-05-02 2012-02-21 用於刺激免疫反應的產品和方法 HK1161542A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4981408P 2008-05-02 2008-05-02
PCT/GB2009/001111 WO2009133378A2 (en) 2008-05-02 2009-05-05 Products and methods for stimulating an immune response

Publications (1)

Publication Number Publication Date
HK1161542A1 true HK1161542A1 (zh) 2012-07-27

Family

ID=40888253

Family Applications (3)

Application Number Title Priority Date Filing Date
HK12101706.9A HK1161542A1 (zh) 2008-05-02 2012-02-21 用於刺激免疫反應的產品和方法
HK14104252.9A HK1190942A1 (zh) 2008-05-02 2014-05-05 用於刺激免疫反應的產品和方法
HK14104596.4A HK1191548A1 (zh) 2008-05-02 2014-05-15 用於刺激免疫反應的產品和方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK14104252.9A HK1190942A1 (zh) 2008-05-02 2014-05-05 用於刺激免疫反應的產品和方法
HK14104596.4A HK1191548A1 (zh) 2008-05-02 2014-05-15 用於刺激免疫反應的產品和方法

Country Status (9)

Country Link
US (1) US20110280930A1 (zh)
EP (3) EP2711020B1 (zh)
JP (3) JP5721620B2 (zh)
CN (1) CN102170903B (zh)
AU (1) AU2009241645B2 (zh)
CA (1) CA2723226A1 (zh)
ES (1) ES2570973T3 (zh)
HK (3) HK1161542A1 (zh)
WO (1) WO2009133378A2 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2711020B1 (en) * 2008-05-02 2016-08-10 BliNK Therapeutics Limited Products and methods for stimulating an immune response
EP2654779B1 (en) 2010-12-23 2018-02-28 Ludwig Institute for Cancer Research, Ltd. Liposomal formulation of nonglycosidic ceramides and uses thereof
TW201442739A (zh) * 2013-02-27 2014-11-16 Riken 過敏疾病治療藥
GB2514591A (en) 2013-05-30 2014-12-03 Mologen Ag Predictive biomarker for cancer therapy
AU2014292926B2 (en) 2013-07-25 2020-03-05 Exicure Operating Company Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
US20170000875A1 (en) * 2013-12-02 2017-01-05 Arytha Biosciences, Llc Toxoid preparation and uses thereof
CN106163504B (zh) 2014-03-20 2021-02-09 加利福尼亚大学董事会 水凝胶毒素-吸收或结合纳米颗粒
PL3164113T3 (pl) 2014-06-04 2019-09-30 Exicure, Inc. Wielowartościowe dostarczanie modulatorów immunologicznych w liposomowych kolistych kwasach nukleinowych do zastosowań profilaktycznych lub terapeutycznych
JP7094533B2 (ja) * 2015-04-10 2022-07-04 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫細胞捕捉デバイスおよびその製造および使用方法
CN107530285B (zh) 2015-04-29 2021-07-27 加利福尼亚大学董事会 使用纳米粒子解毒
CN107708740A (zh) * 2015-06-10 2018-02-16 萨尔布吕肯大学 用于治疗b细胞恶性肿瘤的手段和方法
JP7138864B2 (ja) 2016-02-06 2022-09-20 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫を再構成するための造血ニッチの再現
NL2017204B1 (en) * 2016-06-08 2017-12-18 Kei International Ltd Solid substrate comprising antigens immobilised thereto, biosensor comprising said solid substrate and method for detecting the presence of mycobacterial material in a sample
WO2017211316A1 (en) 2016-06-08 2017-12-14 Kei International Limited Method for detecting the presence of mycobacterial material in a sample using at least two antigens
CN109789092A (zh) 2016-07-13 2019-05-21 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
US20190365657A1 (en) * 2016-08-17 2019-12-05 Orbis Health Solutions, Llc Tumor-targeting bead vectors and methods of using the same
WO2019032862A1 (en) * 2017-08-10 2019-02-14 Dana-Farber Cancer Institute, Inc. CELLS EXPRESSING LMP1 AND METHODS OF USE
EP3650466A1 (en) * 2018-11-12 2020-05-13 Consejo Superior De Investigaciones Científicas In vitro production of high affinity monoclonal antibodies
CN111229023B (zh) * 2018-11-29 2022-01-28 内蒙古东盛硅藻土科技创新产业园有限公司 一种化学降解添加剂
CN112300987B (zh) * 2020-10-16 2022-04-29 中国农业大学 单个浆细胞的筛选方法及其在小分子单克隆抗体制备中的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
DE59010422D1 (de) 1989-12-22 1996-08-22 Mikrogen Molekularbiol Entw Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ZA921025B (en) 1991-02-15 1992-11-25 Uab Research Foundation Structural gene of pneumococcal protein
EP0878545A3 (en) 1991-08-15 1998-12-16 SMITHKLINE BEECHAM BIOLOGICALS s.a. OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines
AU2903892A (en) 1991-10-22 1993-05-21 Symbicom Aktiebolag Improvement in (borrelia burgdorferi) diagnosis and prophylaxis
US5776427A (en) 1992-03-05 1998-07-07 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
US6004763A (en) * 1992-09-11 1999-12-21 Institut Pasteur Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
FR2695563B1 (fr) * 1992-09-11 1994-12-02 Pasteur Institut Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
CA2196311A1 (en) 1994-08-19 1996-02-29 David H. Sachs Genetically engineered swine cells
CN1561389A (zh) 2001-07-25 2005-01-05 纽约大学 糖基神经酰胺作为用于抗传染病和癌症的疫苗的佐剂的用途
DE10164309A1 (de) * 2001-12-28 2003-07-10 Fraunhofer Ges Forschung Verbesserte strukturiert-funktionale Bindematrices für Biomoleküle
AU2003263212A1 (en) * 2002-08-14 2004-03-03 Avidis Sa Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
EP1597280B2 (en) 2003-02-26 2016-08-24 Institute for Research in Biomedicine Monoclonal antibody production by ebv transformation of b cells
JP2008504216A (ja) * 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド モノクローナル抗体の生成のための方法および組成物
ES2389080T3 (es) 2004-06-11 2012-10-23 Riken Fármaco que presenta un ligando de células reguladoras contenido en el liposoma
CN1980638B (zh) * 2004-07-07 2011-10-12 国立血清研究所 用糖脂稳定基于脂质的佐剂制剂的组合物和方法
US9079765B2 (en) * 2004-10-01 2015-07-14 Midatech Ltd. Nanoparticles comprising antigens and adjuvants, and immunogenic structures
CA2599329A1 (en) * 2005-03-02 2006-09-08 The Secretary Of State For Defence Pharmaceutical composition
US8039670B2 (en) 2005-10-25 2011-10-18 Ludwig Institute For Cancer Research Analogs of alpha galactosyceramide and uses thereof
WO2007051004A2 (en) 2005-10-28 2007-05-03 The Brigham And Women's Hospital, Inc. Conjugate vaccines for non-proteinaceous antigens
US20070231344A1 (en) 2005-10-28 2007-10-04 The Brigham And Women's Hospital, Inc. Conjugate vaccines for non-proteinaceous antigens
EP2711020B1 (en) * 2008-05-02 2016-08-10 BliNK Therapeutics Limited Products and methods for stimulating an immune response
JP5782775B2 (ja) 2011-03-29 2015-09-24 ソニー株式会社 情報表示装置および情報表示方法、並びにプログラム

Also Published As

Publication number Publication date
WO2009133378A2 (en) 2009-11-05
ES2570973T3 (es) 2016-05-23
JP2015038066A (ja) 2015-02-26
JP5721620B2 (ja) 2015-05-20
EP2711021A1 (en) 2014-03-26
AU2009241645B2 (en) 2014-07-17
JP2011519847A (ja) 2011-07-14
EP2288381A2 (en) 2011-03-02
US20110280930A1 (en) 2011-11-17
EP2711020B1 (en) 2016-08-10
AU2009241645A1 (en) 2009-11-05
CN102170903B (zh) 2016-04-06
CA2723226A1 (en) 2009-05-11
JP2015028023A (ja) 2015-02-12
JP5853068B2 (ja) 2016-02-09
EP2711020A1 (en) 2014-03-26
EP2711021B1 (en) 2016-03-09
HK1190942A1 (zh) 2014-07-18
HK1191548A1 (zh) 2014-08-01
CN102170903A (zh) 2011-08-31
WO2009133378A3 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
HK1191548A1 (zh) 用於刺激免疫反應的產品和方法
IL215292A0 (en) Compounds and methods for modulating an immune response
IL210677A0 (en) Method and assembly for three-diamensional products
GB0813709D0 (en) Method and product
EP2322672A4 (en) HEATING DEVICE AND HEATING METHOD
GB201102360D0 (en) Cooking apparatus and method
ZA201103050B (en) Systems and methods for providing products to animals
HK1150174A1 (zh) 免疫系統模擬裝置和方法
GB2472545B (en) System and methods for food processing
GB0819720D0 (en) Methods and products
EP2424990A4 (en) COMPOSITIONS AND METHODS FOR ENHANCING SPECIFIC IMMUNE RESPONSES OF ANTIGEN
GB0805473D0 (en) Method and article
HK1212698A1 (zh) 噻唑基和噁唑基異喹哪啶以及它們的使用方法
GB0812933D0 (en) Novel products and method
EP2155239A4 (en) METHOD FOR REDUCING IMMUNE RESPONSE AND TREATMENT OF IMMUNE DISEASES
EP2114416A4 (en) METHOD FOR TRIGGERING AN IMMUNE RESPONSE
EP2554239A4 (en) POWER-ON DEVICE AND POWER-UP METHOD
EP2498807A4 (en) COMPOSITION, METHODS, AND APPLICATIONS OF STIMULATION OF IMMUNE RESPONSES
GB2476767B (en) Method of modifying the immune response
GB201003082D0 (en) Heating apparatus and method
GB0921525D0 (en) Product and method
PL2186576T3 (pl) Sposób i urządzenie do sortowania produktów
GB0817710D0 (en) Method and device for the cooking of foodstuffs
EP2255823A4 (en) GUT IMMUNE-STIMULATOR
GB0803731D0 (en) Methods and products

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210505